Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940422023> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2940422023 endingPage "400" @default.
- W2940422023 startingPage "395" @default.
- W2940422023 abstract "Background: JAK2V617F mutation is the most prevalent molecular abnormality in myeloproliferative neoplasms (MPNs) and has become a valuable marker for diagnosis of MPNs. Almost all patients with polycythemia vera (PV) have this acquired mutation. However, it has also been found in many other hematological diseases, and some studies even detected the presence of JAK2V617F in normal blood samples.Objectives: To discuss the actual need to defer blood donors with high hematocrit.Patients and methods: This prospective case control study was started on 16th of December 2012 and completed on 8th of July 2013, and enrolled 94 male blood donors who attended the National Blood Transfusion Center (NBTC) in Baghdad, Iraq. Their age range was between 21 and 62 years, and their hematocrit was ≥ 0.48 l/l. A control group of 20 patients known to have JAK2V617F positive PV were also included. The following investigations were done for both the study and the control groups: complete blood count, serum erythropoietin, and real time PCR for JAK2V617F detection.Results: The present study found that 21.3% (20/ 94) of healthy blood donors were positive for JAK2V617F mutation. The mutant ratio was higher in the PV control than positive JAK2V617F donors (p=0.001). Out of 20 donors who have positive JAK2V617F mutation, 90% were smokers, and 22.8% (18/79) of all smokers were positive for JAK2V617F, while 13.3% (2/15) of non-smokers showed positivity for the mutation, the difference between various types of smoking and the level of JAK2V617F mutation among study groups was statistically insignificant with a p-value of 0.356. There is a frequent association of pruritis with JAK2 positivity as the percentage of pruritis in JAK2V617F positive blood donors was 40%. There was significant statistical difference between donors with positive JAK2V617F mutation and the PV control group for the hematocrit, total WBC count, absolute neutrophil count, and platelet count with p-values of (0.002), (0.001), (0.001), and (0.001) respectively.Conclusion: The frequency of JAK2V617F mutation was much higher than that anticipated for blood donors. The blood donated from individuals with upper normal hematocrit does not necessarily denote to complete safety of blood as being devoid of JAK2V617F mutation." @default.
- W2940422023 created "2019-04-25" @default.
- W2940422023 creator A5017245003 @default.
- W2940422023 creator A5049522818 @default.
- W2940422023 creator A5059110320 @default.
- W2940422023 date "2014-12-31" @default.
- W2940422023 modified "2023-09-23" @default.
- W2940422023 title "Detection of JAK2V617F tyrosine kinase mutation and estimation of serum erythropoietin in blood donors who have high hematocrit" @default.
- W2940422023 cites W1574897564 @default.
- W2940422023 cites W2026644362 @default.
- W2940422023 cites W2031719814 @default.
- W2940422023 cites W2044515712 @default.
- W2940422023 cites W2048247098 @default.
- W2940422023 cites W2060988701 @default.
- W2940422023 cites W2068265836 @default.
- W2940422023 cites W2070883318 @default.
- W2940422023 cites W2079532825 @default.
- W2940422023 cites W2093290834 @default.
- W2940422023 cites W2116943745 @default.
- W2940422023 cites W2128390912 @default.
- W2940422023 cites W2148366180 @default.
- W2940422023 cites W2149849392 @default.
- W2940422023 cites W2267684534 @default.
- W2940422023 doi "https://doi.org/10.32007/med.1936/jfacmedbagdad.v56i4.12" @default.
- W2940422023 hasPublicationYear "2014" @default.
- W2940422023 type Work @default.
- W2940422023 sameAs 2940422023 @default.
- W2940422023 citedByCount "1" @default.
- W2940422023 countsByYear W29404220232022 @default.
- W2940422023 crossrefType "journal-article" @default.
- W2940422023 hasAuthorship W2940422023A5017245003 @default.
- W2940422023 hasAuthorship W2940422023A5049522818 @default.
- W2940422023 hasAuthorship W2940422023A5059110320 @default.
- W2940422023 hasBestOaLocation W29404220231 @default.
- W2940422023 hasConcept C126322002 @default.
- W2940422023 hasConcept C188816634 @default.
- W2940422023 hasConcept C2778534260 @default.
- W2940422023 hasConcept C2778837598 @default.
- W2940422023 hasConcept C2780959883 @default.
- W2940422023 hasConcept C71924100 @default.
- W2940422023 hasConcept C90924648 @default.
- W2940422023 hasConceptScore W2940422023C126322002 @default.
- W2940422023 hasConceptScore W2940422023C188816634 @default.
- W2940422023 hasConceptScore W2940422023C2778534260 @default.
- W2940422023 hasConceptScore W2940422023C2778837598 @default.
- W2940422023 hasConceptScore W2940422023C2780959883 @default.
- W2940422023 hasConceptScore W2940422023C71924100 @default.
- W2940422023 hasConceptScore W2940422023C90924648 @default.
- W2940422023 hasIssue "4" @default.
- W2940422023 hasLocation W29404220231 @default.
- W2940422023 hasOpenAccess W2940422023 @default.
- W2940422023 hasPrimaryLocation W29404220231 @default.
- W2940422023 hasRelatedWork W1498640978 @default.
- W2940422023 hasRelatedWork W1636947313 @default.
- W2940422023 hasRelatedWork W1980025102 @default.
- W2940422023 hasRelatedWork W2044426036 @default.
- W2940422023 hasRelatedWork W2047458719 @default.
- W2940422023 hasRelatedWork W2054260213 @default.
- W2940422023 hasRelatedWork W2387121035 @default.
- W2940422023 hasRelatedWork W2387442301 @default.
- W2940422023 hasRelatedWork W2536413047 @default.
- W2940422023 hasRelatedWork W2567721812 @default.
- W2940422023 hasRelatedWork W2911358144 @default.
- W2940422023 hasRelatedWork W3028821932 @default.
- W2940422023 hasRelatedWork W3191562841 @default.
- W2940422023 hasRelatedWork W3206015251 @default.
- W2940422023 hasRelatedWork W336879245 @default.
- W2940422023 hasVolume "56" @default.
- W2940422023 isParatext "false" @default.
- W2940422023 isRetracted "false" @default.
- W2940422023 magId "2940422023" @default.
- W2940422023 workType "article" @default.